Icon

TIKOSYN (nda020931)- (0.125MG,0.25MG,0.5MG)

DOFETILIDE PFIZER
0.125MG,0.25MG,0.5MG
Yes No
2018-Oct-09 Expired
None None
None No
TIKOSYN is indicated for the maintenance of normal sinus rhythm (delay in time to recurrence of atrial fibrillation/atrial flutter [AF/AFl]) in patients with atrial fibrillation/atrial flutter of greater than one week duration who have been converted to normal sinus rhythm. TIKOSYN is indicated for the conversion of atrial fibrillation and atrial flutter to normal sinus rhythm.
10 0 7
Total Other Developers 8
Drugs with Suitability No
0.125MG ** ** - - 7
0.25MG ** ** - - 6
0.5MG ** ** Up - 7
NDA Sales Available Total Generic Sales Available
Yes 7
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ** ****** **** ** ******** **********, ***. *********** **** **** *******, **********, ***** ******** (**) *****, ****** ****** (***) ***
****** ********** **** *** ********** ************, *** *********** **** ******** *****, ********, ************ (**) *****, ****** ****** (***) ***
****** ********** ***** ****** *** *********** *** *** *** ********* ** ***** *, *, *-* & *, **********, *** ****** (**) *****-****, ****** ****** (***) ***
****** *** ***** *** ************** ********** ******* *********** ****** **. ****, *****, ***** ********* ** ***** *** ***** ****** *** ***** *** *** ******, ***** (***) ***
****** ********* ****** *** *** ********** ******* *********** ****-**, **** **.**, *****, *.*.***, ******** *******, ********* ******, ******** ********, ********, ****** ******* ******, ***** (***) ***
****** *** *** ************ ******* ******* *********** ************ ********, ****-**, ****** ***. ****& **** ** ****, ********* (*******), ********* (******), ********** ********, ********* ******, ***** (***) ***
****** ****** ******** ***** *************** ******* *********** **** **. * ** **, *******, **** ******* ******, *******-***** *******, **. *-*, ****** ******, *********, ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.